Xingbo Long

457 total citations
30 papers, 302 citations indexed

About

Xingbo Long is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Cancer Research. According to data from OpenAlex, Xingbo Long has authored 30 papers receiving a total of 302 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 11 papers in Surgery and 7 papers in Cancer Research. Recurrent topics in Xingbo Long's work include Bladder and Urothelial Cancer Treatments (9 papers), Prostate Cancer Diagnosis and Treatment (7 papers) and Urinary and Genital Oncology Studies (7 papers). Xingbo Long is often cited by papers focused on Bladder and Urothelial Cancer Treatments (9 papers), Prostate Cancer Diagnosis and Treatment (7 papers) and Urinary and Genital Oncology Studies (7 papers). Xingbo Long collaborates with scholars based in China, United States and Australia. Xingbo Long's co-authors include Yuan Li, Lin Qi, Tongxiang Diao, Wei Xiong, Zhi Chen, Huichuan Jiang, Yi Cai, Miao Mo, Maolin Hu and Lingfeng Meng and has published in prestigious journals such as PLoS ONE, Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Xingbo Long

26 papers receiving 301 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xingbo Long China 9 134 115 102 86 63 30 302
Zhi‐Gang Sun China 12 155 1.2× 94 0.8× 87 0.9× 66 0.8× 73 1.2× 46 369
Manuelita Mazza Italy 12 40 0.3× 69 0.6× 197 1.9× 21 0.2× 127 2.0× 15 339
Samuel H. Lai United States 8 159 1.2× 29 0.3× 132 1.3× 95 1.1× 52 0.8× 15 372
Aaron Prendergast United Kingdom 10 127 0.9× 179 1.6× 166 1.6× 158 1.8× 81 1.3× 21 362
Jordan Kardos United States 7 111 0.8× 78 0.7× 80 0.8× 129 1.5× 51 0.8× 11 254
David Morris United States 8 64 0.5× 102 0.9× 68 0.7× 65 0.8× 39 0.6× 25 224
Maria Grazia Mameli Italy 7 118 0.9× 135 1.2× 115 1.1× 43 0.5× 49 0.8× 11 304
Thiru Prasanna Australia 10 99 0.7× 71 0.6× 198 1.9× 88 1.0× 37 0.6× 17 322
Jeannine Garnett United States 9 132 1.0× 96 0.8× 106 1.0× 38 0.4× 69 1.1× 17 317
Sidrah Shah United Kingdom 9 128 1.0× 97 0.8× 168 1.6× 40 0.5× 102 1.6× 11 371

Countries citing papers authored by Xingbo Long

Since Specialization
Citations

This map shows the geographic impact of Xingbo Long's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingbo Long with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingbo Long more than expected).

Fields of papers citing papers by Xingbo Long

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingbo Long. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingbo Long. The network helps show where Xingbo Long may publish in the future.

Co-authorship network of co-authors of Xingbo Long

This figure shows the co-authorship network connecting the top 25 collaborators of Xingbo Long. A scholar is included among the top collaborators of Xingbo Long based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingbo Long. Xingbo Long is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Jiong, et al.. (2025). BUB1-based risk model predicts prostate cancer prognosis and reveals therapeutic vulnerabilities. European journal of medical research. 30(1). 812–812.
2.
Zhang, Xiyang, Dilong Chen, Hua Yang, et al.. (2025). Eupalinolide A inhibits cancer progression and induces ferroptosis and apoptosis by targeting the AMPK/mTOR/SCD1 signalling in non-small cell lung cancer. Frontiers in Pharmacology. 16. 1649314–1649314.
3.
4.
5.
Long, Xingbo, et al.. (2025). Trends in nanobody radiotheranostics. European Journal of Nuclear Medicine and Molecular Imaging. 52(6). 2225–2238. 7 indexed citations
6.
Tan, Dandan, Yidan Liu, Huaxia Luo, et al.. (2024). A novel mouse model for LAMA2-related muscular dystrophy with analysis of molecular pathogenesis and clinical phenotype. eLife. 13. 1 indexed citations
7.
Long, Xingbo, et al.. (2024). Enhanced prostatic Esr1+ luminal epithelial cells in the absence of SRD5A2. The Journal of Pathology. 263(3). 300–314. 3 indexed citations
8.
Kang, Ning, Zhaohui Zhou, Xingbo Long, et al.. (2023). Targeting the Metabolic Enzyme PGAM2 Overcomes Enzalutamide Resistance in Castration-Resistant Prostate Cancer by Inhibiting BCL2 Signaling. Cancer Research. 83(22). 3753–3766. 8 indexed citations
9.
Liu, Jingying, et al.. (2023). C1q/TNF‐related protein 4 mediates proliferation and migration of vascular smooth muscle cells during vascular remodelling. Clinical and Translational Medicine. 13(5). e1261–e1261. 3 indexed citations
10.
Zhang, Sichen, et al.. (2021). Intrauterine Adhesions (IUAs) or Asherman’s Syndrome (AS) and the Stem Cells Treatment: A Systemic Review and Meta-Analysis. Journal of Biosciences and Medicines. 9(1). 105–118.
11.
Meng, Lingfeng, Zijian Tian, Xingbo Long, et al.. (2021). Caspase 4 Overexpression as a Prognostic Marker in Clear Cell Renal Cell Carcinoma: A Study Based on the Cancer Genome Atlas Data Mining. Frontiers in Genetics. 11. 600248–600248. 14 indexed citations
12.
13.
Long, Xingbo, Huimin Hou, Xuan Wang, et al.. (2020). Immune signature driven by ADT-induced immune microenvironment remodeling in prostate cancer is correlated with recurrence-free survival and immune infiltration. Cell Death and Disease. 11(9). 779–779. 39 indexed citations
14.
Tian, Zijian, Lingfeng Meng, Xingbo Long, et al.. (2020). DNA methylation-based classification and identification of bladder cancer prognosis-associated subgroups. Cancer Cell International. 20(1). 255–255. 12 indexed citations
15.
Lai, Shicong, Pengjie Wu, Jianyong Liu, et al.. (2020). Oncological impact of different distal ureter managements during radical nephroureterectomy for primary upper urinary tract urothelial carcinoma. World Journal of Clinical Cases. 8(21). 5104–5115. 3 indexed citations
16.
Wang, Zongwei, Tuo Deng, Xingbo Long, et al.. (2020). Methylation of SRD5A2 promoter predicts a better outcome for castration-resistant prostate cancer patients undergoing androgen deprivation therapy. PLoS ONE. 15(3). e0229754–e0229754. 8 indexed citations
17.
Wu, Xiaobo, Xingbo Long, Chen Yang, et al.. (2020). Icaritin reduces prostate cancer progression via inhibiting high-fat diet-induced serum adipokine in TRAMP mice model. Journal of Cancer. 11(22). 6556–6564. 7 indexed citations
18.
Long, Xingbo, Wei Xiong, Lin Qi, et al.. (2019). Cancer-associated fibroblasts promote cisplatin resistance in bladder cancer cells by increasing IGF-1/ERβ/Bcl-2 signalling. Cell Death and Disease. 10(5). 375–375. 105 indexed citations
19.
Long, Xingbo, Qi Lin, Zhenyu Ou, et al.. (2017). Evolving use of social media among Chinese urologists: Opportunity or challenge?. PLoS ONE. 12(7). e0181895–e0181895. 21 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhi‐Gang Sun Breakdown of academic impact, for papers by Manuelita Mazza Breakdown of academic impact, for papers by Samuel H. Lai Breakdown of academic impact, for papers by Aaron Prendergast Breakdown of academic impact, for papers by Jordan Kardos Breakdown of academic impact, for papers by David Morris Breakdown of academic impact, for papers by Maria Grazia Mameli Breakdown of academic impact, for papers by Thiru Prasanna Breakdown of academic impact, for papers by Jeannine Garnett Breakdown of academic impact, for papers by Sidrah Shah
Rankless by CCL
2026